Myeloid Lineage Differentiation and Osteoclast Priming by a Novel Pax5 Cytokine

新型 Pax5 细胞因子的骨髓谱系分化和破骨细胞启动

基本信息

  • 批准号:
    8581522
  • 负责人:
  • 金额:
    $ 21.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Bone marrow is the source of osteogenic, hematopoietic, and immune cells. It is now well accepted that osteoclasts, like macrophages, granulocytes and dendritic cells, are members of the myeloid lineage arising from hematopoietic stem cells. During the early stages of hematopoietic cell differentiation multipotential progenitor (MPP) cells can give rise to either myeloid progenitors or B lymphocyte progenitors. These early cell fate decisions are regulated, in part, by the expression or repression of proteins under the control of a series of transcription factors (TFs), which include, PU.1, Ikaros, E2A, Ebf1, Pax5 and Gon4-like. With the exception of PU.1 and Ikaros the other TFs are most often associated with B cell differentiation. However, we and others have shown that some of these TFs play an important role in bone cell development. How these TFs regulate the early cell fate choice between osteoclast and B cell differentiation is however only starting to be explored but with little direct data available. This regulation takes on added significance because of data showing that immune cells can be potent regulators of osteoclast differentiation. We have begun an analysis of mice deficient in Pax5, a TF required for commitment and maintenance of the B cell lineage. These animals experience a developmental block in B cell differentiation resulting in a phenotype characterized by the absence of most B cells. Importantly, these mice are also severely runted; they develop strikingly decreased trabecular bone mass with markedly increased numbers of osteoclasts. We have been able to isolate and characterize an adherent cell population from the spleen of Pax5-/- mice that grows continuously in culture without added growth factors and can give rise to osteoclasts, macrophages and dendritic cells. In addition, these cells secrete a cytokine(s) that induces proliferation and primes wild-type cells to also become myeloid progenitor cells. It is our hypothesis that the loss of Pax5 leads to the derepression of specific genes that allow the secretion of this novel cytokine(s), which induces myeloid progenitor cell differentiation resulting in increased osteoclastogenesis and this in turn produces the resultant bone phenotype. In broader terms, loss of Pax5 may have revealed a new pathway that regulates myeloid cell differentiation and specifically osteoclasts. The goal of this proposal is to identify that cytokine(s) and thus the mechanism(s) by which Pax5 regulates myeloid cell differentiation.
描述(由申请人提供):骨髓是成骨细胞、造血细胞和免疫细胞的来源。破骨细胞与巨噬细胞、粒细胞和树突状细胞一样,都是源自造血干细胞的髓系细胞。早期造血细胞分化为多潜能祖细胞

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARK C HOROWITZ其他文献

MARK C HOROWITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARK C HOROWITZ', 18)}}的其他基金

The Sixth International Conference on Osteoimmunology: Interactions of the Immune and Skeletal Systems
第六届国际骨免疫学会议:免疫与骨骼系统的相互作用
  • 批准号:
    9117878
  • 财政年份:
    2016
  • 资助金额:
    $ 21.23万
  • 项目类别:
The Fifth International Conference on Osteoimmunology: Interactions of the Immune
第五届国际骨免疫学会议:免疫的相互作用
  • 批准号:
    8709156
  • 财政年份:
    2014
  • 资助金额:
    $ 21.23万
  • 项目类别:
Myeloid Lineage Differentiation and Osteoclast Priming by a Novel Pax5 Cytokine
新型 Pax5 细胞因子的骨髓谱系分化和破骨细胞启动
  • 批准号:
    8692538
  • 财政年份:
    2013
  • 资助金额:
    $ 21.23万
  • 项目类别:
CELL CORE
细胞核心
  • 批准号:
    8376753
  • 财政年份:
    2012
  • 资助金额:
    $ 21.23万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8328698
  • 财政年份:
    2011
  • 资助金额:
    $ 21.23万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8698743
  • 财政年份:
    2011
  • 资助金额:
    $ 21.23万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8496032
  • 财政年份:
    2011
  • 资助金额:
    $ 21.23万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
  • 批准号:
    8183483
  • 财政年份:
    2011
  • 资助金额:
    $ 21.23万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance
骨髓肥胖、矿物质代谢和能量平衡的跨学科研究
  • 批准号:
    9769004
  • 财政年份:
    2011
  • 资助金额:
    $ 21.23万
  • 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance
骨髓肥胖、矿物质代谢和能量平衡的跨学科研究
  • 批准号:
    8967832
  • 财政年份:
    2011
  • 资助金额:
    $ 21.23万
  • 项目类别:

相似海外基金

Histone H3.3-dependent transcriptional control and B cell differentiation
组蛋白 H3.3 依赖性转录控制和 B 细胞分化
  • 批准号:
    DP230102695
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Discovery Projects
FCRL1 in B cell differentiation
FCRL1 在 B 细胞分化中的作用
  • 批准号:
    10730705
  • 财政年份:
    2023
  • 资助金额:
    $ 21.23万
  • 项目类别:
Mechanisms of pathogenic B cell differentiation associated with genetic risk for systemic lupus erythematosus.
与系统性红斑狼疮遗传风险相关的致病性 B 细胞分化机制。
  • 批准号:
    21H02960
  • 财政年份:
    2021
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Roles for S-adenosylmethionine in B cell differentiation and activation
S-腺苷甲硫氨酸在 B 细胞分化和激活中的作用
  • 批准号:
    21K20770
  • 财政年份:
    2021
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
An enhanced mitochondrial function via glutaminolysis in human B cell differentiation: a potential therapeutic target for type 1 diabetes mellitus
通过人类 B 细胞分化中的谷氨酰胺分解增强线粒体功能:1 型糖尿病的潜在治疗靶点
  • 批准号:
    20K17524
  • 财政年份:
    2020
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
B cell differentiation in the germinal center reaction and the resulting memory B cell compartment in humans
人类生发中心反应中的 B 细胞分化以及由此产生的记忆 B 细胞区室
  • 批准号:
    418103381
  • 财政年份:
    2019
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Research Grants
Mechanism of human B cell differentiation via amino-acid metabolism -Development of novel therapy for systemic lupus erythematosus-
人类B细胞通过氨基酸代谢分化的机制 -系统性红斑狼疮新疗法的开发-
  • 批准号:
    19K08900
  • 财政年份:
    2019
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Epigenetic Regulation of Memory B Cell Differentiation and Reactivation
记忆 B 细胞分化和再激活的表观遗传调控
  • 批准号:
    9761825
  • 财政年份:
    2018
  • 资助金额:
    $ 21.23万
  • 项目类别:
Orchestration of memory B cell differentiation controlled by the regulation of IRF4 protein degradation
IRF4 蛋白降解调节控制记忆 B 细胞分化
  • 批准号:
    16K19026
  • 财政年份:
    2016
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Elucidation of the mechanism for regulatory B cell differentiation by nephronectin and establishment of a novel therapeutic strategy for autoimmune diseases
阐明肾连接素调节B细胞分化的机制并建立自身免疫性疾病的新治疗策略
  • 批准号:
    16K08221
  • 财政年份:
    2016
  • 资助金额:
    $ 21.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了